| |
| |
|
| Insider
Information: |
Yancopoulos George |
| Relationship: |
Bd. Co-Chair, Presiden... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
868,994 |
|
|
Indirect Shares
|
241,951 |
|
|
| Direct
Value |
$900,729,661 |
|
|
|
Indirect Value
|
$250,787,051 |
|
|
| Total
Shares |
1,110,945 |
|
|
| Total
Value |
$1,151,516,711 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
Bd. Co-Chair, Presiden... |
2024-06-10 |
868,994 |
2024-06-10 |
241,951 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
147 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2018-08-22 |
4 |
GD |
$0.00 |
$0 |
I/I |
3,211 |
484,777 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2018-11-01 |
4 |
GD |
$0.00 |
$0 |
I/I |
24,643 |
0 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2018-11-16 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,176 |
483,601 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2018-12-13 |
4 |
GA |
$0.00 |
$0 |
I/I |
118,993 |
602,594 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2018-12-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
118,993 |
0 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2018-12-13 |
4 |
D |
$377.31 |
$47,184,502 |
D/D |
(125,055) |
118,993 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2018-12-13 |
4 |
OE |
$16.80 |
$4,100,006 |
D/D |
244,048 |
167,185 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2019-02-19 |
4 |
GA |
$0.00 |
$0 |
I/I |
150,722 |
753,316 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2019-02-19 |
4 |
GD |
$0.00 |
$0 |
I/I |
150,722 |
249,278 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2019-06-13 |
4 |
GD |
$0.00 |
$0 |
I/I |
500,000 |
253,316 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2019-06-13 |
4 |
GA |
$0.00 |
$0 |
I/I |
500,000 |
500,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2019-08-05 |
4 |
GA |
$0.00 |
$0 |
I/I |
75,036 |
328,352 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2019-08-05 |
4 |
GD |
$0.00 |
$0 |
I/I |
75,036 |
0 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2019-11-14 |
4 |
GD |
$0.00 |
$0 |
I/I |
2,366 |
325,989 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2019-11-18 |
4 |
GA |
$0.00 |
$0 |
D/D |
325,986 |
325,986 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2019-11-18 |
4 |
GD |
$0.00 |
$0 |
I/I |
325,986 |
0 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2019-12-12 |
4 |
D |
$377.16 |
$47,964,192 |
D/D |
(127,172) |
444,109 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2019-12-12 |
4 |
OE |
$21.25 |
$5,212,519 |
D/D |
245,295 |
521,876 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2020-02-24 |
4 |
AS |
$420.17 |
$49,631,741 |
D/D |
(118,123) |
517,799 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2020-03-09 |
4 |
D |
$476.42 |
$61,420,543 |
D/D |
(128,921) |
635,614 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2020-03-09 |
4 |
OE |
$30.63 |
$7,557,524 |
D/D |
246,736 |
713,990 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2020-03-10 |
4 |
AS |
$461.79 |
$55,428,041 |
D/D |
(117,815) |
517,799 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2020-07-27 |
4 |
GD |
$0.00 |
$0 |
I/I |
57,465 |
0 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2020-12-30 |
4 |
OE |
$52.03 |
$20,712,050 |
D/D |
398,079 |
908,303 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2020-12-30 |
4 |
D |
$483.25 |
$104,773,433 |
D/D |
(216,810) |
822,207 |
0 |
- |
|
147 Records found
|
|
Page 5 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
